Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xi Su

Showing results (311-320 of 363) with videos related to

Pageof 37
Sort By:
The Journal of Molecular Diagnostics : JMD|March 24, 2023
Development of Multiplex Drop-Off Digital PCR Assays for Hotspot Mutation Detection of KRAS, NRAS, BRAF, and PIK3CA in the Plasma of Colorectal Cancer PatientsQian Yu, Huiqin Jiang, Xi Su, et al.
Journal of the American College of Cardiology|October 17, 2015
Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China TrialRunlin Gao, Yuejin Yang, Yaling Han, et al.
Neuroimage. Clinical|April 8, 2024
Right superior frontal gyrus: A potential neuroimaging biomarker for predicting short-term efficacy in schizophreniaYongfeng Yang, Xueyan Jin, Yongjiang Xue, et al.
Science China. Life Sciences|May 7, 2022
Twin peaks of in-hospital mortality among patients with STEMI across five phases of COVID-19 outbreak in China: a nation-wide studyJianping Li, Nan Zhang, Ziyi Zhou, et al.
Journal of Geriatric Cardiology : JGC|September 21, 2020
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trialXiao-Si Jiang, Li-Chao Tian, Zi-Chao Jiang, et al.
Schizophrenia (Heidelberg, Germany)|August 27, 2024
Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficitsXiaojing Li, Xiujuan Wang, Yongfeng Yang, et al.
JAMA|March 17, 2015
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trialYaling Han, Jincheng Guo, Yang Zheng, et al.
JACC. Cardiovascular Interventions|September 10, 2025
5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold: The NeoVas Randomized TrialKai Xu, Guosheng Fu, Xiaozeng Wang, et al.
The Clinical Respiratory Journal|May 4, 2021
Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in ChinaTao Wang, Ruidi Tang, Honglian Ruan, et al.
Translational Psychiatry|April 10, 2025
Prediction of antipsychotic drug efficacy for schizophrenia treatment based on neural features of the resting-state functional connectomeSong Liu, Meng Wang, Weiyi Han, et al.
Pageof 37

Showing results (311-320 of 363) with videos related to

Sort By:
Pageof 37
The Journal of Molecular Diagnostics : JMD|March 24, 2023
Development of Multiplex Drop-Off Digital PCR Assays for Hotspot Mutation Detection of KRAS, NRAS, BRAF, and PIK3CA in the Plasma of Colorectal Cancer PatientsQian Yu, Huiqin Jiang, Xi Su, et al.
Journal of the American College of Cardiology|October 17, 2015
Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China TrialRunlin Gao, Yuejin Yang, Yaling Han, et al.
Neuroimage. Clinical|April 8, 2024
Right superior frontal gyrus: A potential neuroimaging biomarker for predicting short-term efficacy in schizophreniaYongfeng Yang, Xueyan Jin, Yongjiang Xue, et al.
Science China. Life Sciences|May 7, 2022
Twin peaks of in-hospital mortality among patients with STEMI across five phases of COVID-19 outbreak in China: a nation-wide studyJianping Li, Nan Zhang, Ziyi Zhou, et al.
Journal of Geriatric Cardiology : JGC|September 21, 2020
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trialXiao-Si Jiang, Li-Chao Tian, Zi-Chao Jiang, et al.
Schizophrenia (Heidelberg, Germany)|August 27, 2024
Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficitsXiaojing Li, Xiujuan Wang, Yongfeng Yang, et al.
JAMA|March 17, 2015
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trialYaling Han, Jincheng Guo, Yang Zheng, et al.
JACC. Cardiovascular Interventions|September 10, 2025
5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold: The NeoVas Randomized TrialKai Xu, Guosheng Fu, Xiaozeng Wang, et al.
The Clinical Respiratory Journal|May 4, 2021
Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in ChinaTao Wang, Ruidi Tang, Honglian Ruan, et al.
Translational Psychiatry|April 10, 2025
Prediction of antipsychotic drug efficacy for schizophrenia treatment based on neural features of the resting-state functional connectomeSong Liu, Meng Wang, Weiyi Han, et al.
Pageof 37